Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. IOVA
IOVA logo

IOVA

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IOVA News

Investment Comparison: Heartflow vs Iovance

3d agoNASDAQ.COM

Evaluating AI and Personalized Cell Therapy Investment Opportunities

4d agoFool

Investment Comparison: Amgen vs. Iovance Biotherapeutics

Jun 24 2026Fool

Comparative Investment Analysis of Amgen and Iovance

Jun 24 2026NASDAQ.COM

Amgen vs Iovance: Investment Comparison

Jun 24 2026Yahoo Finance

Iovance Biotherapeutics Files Registration Statement for sec

Jun 18 2026Yahoo Finance

GT Biopharma Advances Three Drug Candidates into Clinical Trials

Jun 08 2026Globenewswire

GT Biopharma Advances Three Cancer Drug Candidates into Clinical Trials

Jun 08 2026Newsfilter

Iovance Biotherapeutics Secures Conditional Approval for Amtagvi in Australia

Jun 04 2026seekingalpha

Iovance Biotherapeutics Stock Volatility Analysis

Jun 02 2026Fool

Iovance Biotherapeutics Stock Volatility and Growth Prospects

Jun 02 2026NASDAQ.COM

Biotech Companies Focus on Drug Delivery Technologies

Jun 01 2026Globenewswire

Biotech Companies Focus on Drug Delivery Technologies

Jun 01 2026Newsfilter

Iovance Expands Tumor Treatment Platform with FDA Approval

Jun 01 2026Newsfilter

Iovance Grants Stock Options to New Employees

May 22 2026Newsfilter

Iovance Reports Wider Than Expected Q1 Loss Amid Approval Delays

May 07 2026stocktwits